Blog


On October 3rd, 2019 LGM Pharma attended the first Women in Life Sciences Brunch! We heard from prominent women with diverse journeys in the life sciences community. Through the Women in Life Sciences Brunch we were able to share insights about how degrees in the life sciences can manifest into exciting and meaningful career paths.[…]

Read More

On September 26 and 27, Contract Pharma hosted its 18th Annual Contracting & Outsourcing Conference & Tabletop Exhibition at the Hyatt Regency in New Brunswick, NJ. The 2019 conference was a great success, with approximately 400 attendees, a sold out exhibit hall featuring 160 contract service providers, and a prestigious line up of speakers covering[…]

Read More

On  Saturday, September 7th, LGM Pharma joined 20 local companies and 600 of #PalmBeachCounty‘s most influential leaders to celebrate economic development success. The 2019 BDB Gala at The Breakers Palm Beach was a success!   About Business Development Board (BDB) The Business Development Board is a private, not-for-profit corporation. Founded in 1982 by Chambers of[…]

Read More

API Sourcing Challenges

Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of sourcing active pharmaceutical ingredients (APIs) and intermediates has also become more challenging. In 2018, ISR Reports looked at how experience and capacity impact small molecule API outsourcing. Among the findings, about 25% of respondents indicated their company lacked the capacity[…]

Read More

On August 7th, 2019, LGM Pharma joined Kelly Smallridge, President & CEO of the Business Development Board for a round table discussion and Economic Development overview, with updates on our Business Retention & Expansion pipeline, as well as the opportunity to ask questions regarding our involvement with the BDB. About Business Development Board (BDB) The[…]

Read More

As cadeias logísticas de empresas farmacêuticas e biofarmacêuticas continuam a crescer cada vez mais complexas e globais. O processo de aquisição de insumos farmacêuticos ativos (IFAs) e intermediários também se tornou mais desafiador. Em 2018, o ISR Reports analisou como experiência e capacidade influenciam na aquisição de IFA de pequenas moléculas. Entre as descobertas, cerca[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service